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Abstract
Objective: The 7th edition of AJCC staging manual implicitly states that only T1 and T2 lesions that lack regional lymph
node metastasis but have tumor deposit(s) will be classified in addition as N1c, though it is not consistent in that pN1c is
also an option for pT3/T4a tumors in the staging table. Nevertheless, in this TNM classification, how to classify tumor
deposits (TDs) in colorectal cancer patients with lymph node metastasis (LNM) and TDs simultaneously is still not clear. The
aim of this study is to investigate the possibility of counting TDs as metastatic lymph nodes in TNM classification and to
indentify its prognostic value for colorectal cancer patients.
Methods and Results: In this retrospective study, 513 cases of colorectal cancer with LNM were reviewed. We proposed a
novel pN (npN) category in which TDs were counted as metastatic lymph nodes in the TNM classification. Cancer-specific
survival according to the npN or pN category was analyzed using Kaplan-Meier survival curves. Univariate and multivariate
analyses were performed to indentify significant prognostic factors. Harrell’s C statistic was used to test the predictive
capacity of the prognostic models. The results revealed that the TD was a significant prognostic factor in colorectal cancer.
Univariate and multivariate analyses uniformly indicated that the npN category was significantly correlated with prognosis.
The results of Harrell’s C statistical analysis demonstrated that the npN category exhibited a superior predictive capacity
compared to the pN category of the 7th edition TNM classification. Moreover, we also found no significant prognostic
differences in patients with or without TD in the same npN categories.
Conclusions: The counting of TDs as metastatic lymph nodes in the TNM classification system is potentially superior to the
classification in the 7th edition of the TNM staging system to assess prognosis and survival for colorectal cancer patients.
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Introduction
Colorectal cancer is the third most common malignancy in both
men and women, and the second leading cause of cancer-related
death in western developed countries [1,2]. Currently, the tumor
stage remains to be the most important determinant of prognosis
in colorectal cancer and it is the basis for the authoritative patient
management guidelines that influence most patient management
decisions. The International Union Against Cancer (UICC)/
American Joint Committee on Cancer (AJCC) TNM classification
system is the principal staging systems utilized and therapeutic
decisions are most often based on this classification system [3].
Great changes in the TNM staging system for colorectal cancer
have occurred from the 5th edition to the 7th edition, particularly
regarding the pN classification [4–6].
Tumor deposits (TDs) are defined as focal aggregates of
adenocarcinoma located in the pericolic or perirectal fat
discontinuous with the primary tumor [7]. Recently, several
studies have reported on prognostic analyses of TDs in colorectal
cancer, and found that the presence of TDs was an important
prognostic factor [8–11]. Colorectal cancer patients with TDs
exhibited a poorer prognosis and lower survival rate compared to
patients without such lesions. Due to the significant value in
clinical practice, TDs were still taken into account in the current
7th edition of TNM classification for colorectal cancer, and a new
pN1c category was proposed. It states that only T1 and T2 lesions
that lack regional lymph node metastasis but have tumor deposit(s)
will be classified in addition as N1c, though it is not consistent in
that pN1c is also an option for pT3/T4a tumors in the staging
table [6]. Although the latest TNM classification states that the
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tion criteria, there are no guidelines on how to classify TDs in
patients with lymph node metastasis(LNM) and TDs simulta-
neously. Therefore, this potentially impacts the accuracy of the
classification, particularly how to assess these patients with
colorectal cancer.
In the 7th edition of AJCC gastric cancer staging, pathologic
assessment of the regional lymph nodes entails their removal and
histologic examination to evaluate the total number of nodes, as
well as the number that contain TDs, and TDs in the fat adjacent
to a gastric regional LNM without evidence of residual lymph
node tissue were considered as LNM [12]. In the light of these
considerations, the aim of the present study is to investigate the
possibility of counting TDs as metastatic lymph nodes in TNM
classification when LNM and TDs exist simultaneously and to
indentify its prognostic value for colorectal cancer patients.
Methods
Participants
Information on all patients with stage III colorectal cancer who
underwent radical surgery at the Department of Surgical
Oncology at the First Hospital of China Medical University from
April 1994 to December 2007 were retrospectively collected,
reviewed, and analyzed. Patients with any of the following criteria
were excluded from the present study: (i) patients who died in the
immediate postoperative period (within 30 days), (ii) patients with
multiple adenocarcinomas of colon and rectum, (iii) patients with
synchronous or metachronous tumors, (iv) patients who underwent
neoadjuvant treatment, (v) patients who were classified as pN1c or
had no LNM, (vi) patients with distant metastasis found
preoperatively, (vii) patients with incomplete pathological data
entries, and (viii) patients who were lost to follow-up. After
considering the above criteria, there were 513 colorectal cancer
patients in our study. The clinical data including age, gender, date
of surgery, date of death (if applicable), cause of death, date of
follow-up, location of the primary tumor, tumor size, histologic
grade, venous invasion, lymphovascular invasion, depth of
invasion, number of lymph nodes retrieved, number of LNM,
and number of TDs were obtained. Tumors originating from
cecum to sigmoid colon were defined as colon cancer, and tumors
located in the rectum or rectosigmoid junction were considered as
rectal cancer [13].
Pathological procedures
Specimens were fixed in formalin and stained with hematoxylin
and eosin(H&E). Sections were examined by two independent
pathologists and confirmed by a third expert to make the final
diagnosis. Disagreements regarding the diagnosis were resolved as
a consensus upon re-review of the slides with all three pathologists
[14].
Classification methods
All patients were firstly classified according to the 7th edition of
the TNM staging system. Then, we utilized a new method to
reclassify all cases with colorectal cancer exhibiting TDs and LNM
simultaneously, namely, we counted TDs as LNM in the novel pN
category. For our study purpose, the novel pN category and the
novel TNM staging system were recorded as npN category and
nTNM staging system.
Follow up
Postoperative follow-up was completed for the entire study
population until November 2008. Median and mean follow-up
periods were 30.72 months and 39.85629.94 months (range: 1.1–
164.3 months), respectively.
Ethics statement
The study was approved by the Research Ethics Committee of
China Medical University, China. Informed consent was obtained
from all patients before participating in the study.
Statistical Analysis
Continuous data were presented as the mean 6 standard
deviation(SD). Cancer-specific survival was analyzed using Ka-
plan-Meier survival curves, and comparisons were made using the
log-rank test. Multivariate analysis was performed using Cox’s
proportional hazards model. The predictive power of the
individual models was evaluated using Harrell’s C statistic. A
model with perfect predictive capacity (sensitivity and specificity of
100%) would have a Harrell’s C statistic of 1.00 and the highest
Harrell’s C statistic was chosen as the best model [15,16].
Statistical analyses and graphics were performed with PASW
Statistics 18.0 software (SPSS, Inc., Somers, NY, USA) and
STATA MP ver.10 (StataCorp LP, College Station, TX) statistical
software. A value of P,0.05 was considered to be statistically
significant.
Results
Clinicopathological features of stage III colorectal cancer
patients are listed in Table 1. Of the 513 patients, there were
277 (54.0%) males and 236 females (46.0%; ratio 1.2:1) with a
mean age of 59.63611.78 years (median 61 years; range 20–85
years). Among these patients, 212 patients (41.3%) had colon
cancer and 301 patients (58.7%) had rectum cancer. TDs were
found in 151 of 513 patients (29.4%), and the mean number of
TDs retrieved was 2.5262.63 (range 1–17). The median and
mean number of lymph nodes metastasis was 2 and 3.4463.58
(range 1–28), respectively. The median and mean number of
lymph nodes retrieved was 11 and 13.0068.75 (range 1–81),
respectively.
Survival curves of 513 patients with colorectal cancer classified
according to the different pN categories are shown in Fig. 1. As
shown in Fig. 1A, upstaging occurred in 88 of 151 patients (58%)
with TDs, and these patients staged by pN category showed a
trend of migrating to a higher classification in nTNM staging
system.There were significant prognostic differences among
patients in the pN1a, pN1b, pN2a, and pN2b subcategories with
regard to the pN category (Fig. 1B, P,0.001). Similarly, according
to the npN category, significant differences were observed in the
prognosis for these four subcategories (Fig. 1C, P,0.001).
However, we found that certain patients showed stage migration
as a result of the changes to the definition of the npN category.
Univariate analysis showed that the pN category, npN category,
TNM classification and nTNM classification were significantly
correlated with prognosis (P,0.001 for all) (Table 1). The
variables pN and npN categories were highly correlated due to
the fact that the npN category can be considered as an adjusted
classification of the pN category. Therefore, multivariable models
for the 513 patients were calculated separately for each variable to
avoid bias in the estimation of variable effects (Table 2, 3). As
shown in Tables 2 and 3, both the pN category and npN category
were identified as independent prognostic factors by multivariate
analyses (P,0.001 for both).
Next, the pN category, TNM classification, npN category and
nTNM classification were measured by Harrell’s C statistic to
identify which has a superior predictive capacity. The results
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CI:0.5939–0.6680) was superior to the pN category (Harrell’s
C=0.6197; 95% CI:0.5821–0.6573). Additionally, between the
TNM classification (Harrell’s C=0.6187; 95% CI:0.5868–0.6507)
and the nTNM classification (Harrell’s C=0.6286; 95%
CI:0.5960–0.6611), the latter was regarded as the perfect
predictive parameter.
To study whether one TD carries the same weight as one
positive lymph node in terms of patient prognosis, we focused on
the patients with pure positive lymph nodes (without TDs) and
compared the survival of patients with the number of TDs plus the
number of LNM to patients with the same npN of pure positive
lymph nodes only. The results showed no prognostic heterogeneity
(Fig. 2, P.0.05).
Discussion
Tumor deposits were first described by Gabriel et al in 1935,
who concluded that these phenomena were the result of vascular
tumor dissemination [17]. Since then, TDs in adjacent adipose
tissue have become a well-known feature of colorectal cancer, and
many studies have investigated the clinical significance of TDs in
patients with colorectal cancer [8–10]. A meta-analysis of the
survival of 3714 colorectal cancer patients confirmed the
correlation of TDs with adverse prognosis, including increased
local recurrence rates and increased development of distant
metastasis [8]. Some authors have suggested that survival of the
patients with such lesions is significantly lower compared to those
without TDs [8,11,18]. Moreover, it has been reported that an
increasing number and diameter of TDs are highly associated with
an even worse clinical outcome [11,18,19]. Therefore, it is clear
that TDs play an important role in the prognosis of colorectal
cancer. In the present study, we examined the 5-year survival of
patients according to clinical variables by univariate analysis. Not
surprisingly, the presence of TDs was an important prognostic
predictor in colorectal cancer. The postoperative 5-year survival of
patients with and without TDs was 33% and 52.9%, respectively,
and the former had a worse disease-free survival compared with
TD-negative patients. We concluded that TDs could be potentially
regarded as an adverse prognostic factor in colorectal cancer. This
is consistent with previous reports that TDs exhibit a strong
correlation with cancer aggressiveness [8,11,18].
The UICC/AJCC TNM staging system, although controver-
sial, is considered as the most powerful and reliable predictor of
prognosis for colorectal cancer patients around the world [20].
Over the past 13 years, this classification system for colorectal
cancer has been revised three times. Whether TDs should be
regarded as pT stage, pN stage, pM stage, or even be excluded
from consideration in determining tumor stage also has changed
several times. The 7th edition of AJCC staging manual implicitly
states that only T1 and T2 lesions that lack regional lymph node
metastasis but have tumor deposit(s) will be classified in addition as
N1c, though it is not consistent in that pN1c is also an option for
pT3/T4a tumors in the staging table. Tong et al, in a study of 1541
patients with colorectal cancer, suggested that the 7th edition of
the TNM staging system on TDs satisfactorily predicted patients’
Table 1. Univariate analysis of the prognostic factors for 513
patients.
n
a 5-YSR
b(%) P
Gender 0.657
Male 277 46.0
Female 236 47.4
Age,year 0.112
#60 252 49.6
.60 261 43.6
Tumor location 0.551
Colon 212 50.6
Rectum 301 44.5
Size 0.784
#5.0 cm 313 46.2
.5.0 cm 200 47.3
Venous invasion 0.117
Positive 9 18.5
Negative 504 47.5
Histologic grade 0.021
Well 189 52.7
Moderate 263 44.2
Poor 61 35.1
Lymphovascular invasion ,0.001
Positive 62 26.0
Negative 451 49.5
The presence or absence of TDs ,0.001
Positive 151 33.0
Negative 362 52.9
pT category ,0.001
pT1+pT2 65 60.0
pT3 352 50.1
pT4 96 29.8
pN category ,0.001
pN1a 172 59.9
pN1b 180 51.0
pN2a 96 32.1
pN2b 65 17.4
npN
c category ,0.001
npN1a 138 60.7
npN1b 167 56.6
npN2a 115 32.9
npN2b 93 22.0
TNM staging system ,0.001
IIIa 56 66.2
IIIb 362 50.8
IIIc 95 20.9
nTNM
d staging system ,0.001
IIIa 53 66.4
IIIb 343 51.1
IIIc 117 23.6
n
a: Number of patients.
5-YSR
b: 5-year accumulative survival rate.
npN
c: novel pN category.
nTNM
d: novel TNM staging system.
doi:10.1371/journal.pone.0034087.t001
Table 1. Cont.
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cancer patients have LNM and TDs simultaneously, the TNM
staging system dose not provide additional guidelines on staging
for these patients. Therefore, the accuracy of the classification in
these patients is potentially affected.
In the 7th edition of AJCC gastric cancer staging, TDs adjacent
to a regional LNM without evidence of lymph node tissue were
considered as LNM, and they were included in the number of
lymph nodes for pathologic staging [12]. Wang et al, in their study
of 1580 cases of gastric cancer, proposed that TDs could be
classified based on their number and prognostic information
should be incorporated into the TNM staging system [22]. In
addition, TDs were generally considered to represent LNM in
Japanese classification of colorectal carcinoma [23]. In the light of
these considerations, we ventured to propose a new method in
which TDs could be counted as LNM to subcategory pN stage in
patients with colorectal cancer.
Univariate and multivariate analyses uniformly demonstrated
that the pN category and npN category were significantly
correlated with patient prognosis. Our results indicated that the
npN category we proposed could satisfactorily predict the
prognostic outcome of patients with colorectal cancer. However,
we also found that stage migration occurred in some patients with
various pN subcategories due to the change in defination. There
was a noticeable trend in which patients with TDs in pN
subcategories were upgraded to a higher stage under the nTNM
classification. To determine whether the npN category and nTNM
classification were superior to the pN category and TNM
classification in terms of prediction capacity, we used Harrell’s C
statistic for data analyses, the results indicated that the npN
category and nTNM classification exhibited a stronger predictive
power compared to the other two models. Moreover, we also
found no significant prognostic differences in patients with or
without TDs in the same npN categories (Fig. 2). It suggested one
Figure 1. Stage migration in 88 patients and survival curves of patients according to the pN category and npN category. A: The
number of patients who had stage migration in different subcategories. B: Survival curves showed different prognostic outcomes among patients
with pN1a, pN1b, pN2a, and pN2b (P,0.001). C: Survival curves showed different prognostic outcomes among patients with npN1a, npN1b, npN2a,
and npN2b (P,0.001).
doi:10.1371/journal.pone.0034087.g001
Table 2. Multivariate Analysis (Cox Proportional Hazard
Model) of Prognostic Factors for 513 Patients with the pN
category.
HR
a 95% CI
b P
pT category ,0.001
pT1+pT2
* 1
pT3 1.127 0.725–1.752
pT4 2.229 1.380–3.598
pN category ,0.001
pN1a
* 1
pN1b 1.265 0.898–1.783
pN2a 1.676 1.148–2.445
pN2b 2.817 1.858–4.272
TDs 1.733 1.322–2.270 ,0.001
Lymphovascular invasion 2.115 1.449–3.087 ,0.001
HR
a: hazard ratio.
CI
b: confidence interval.
*: reference category.
doi:10.1371/journal.pone.0034087.t002
Table 3. Multivariate Analysis (Cox Proportional Hazard
Model) of Prognostic Factors for 513 Patients with the npN
a
category.
HR
a 95% CI
b P
pT category ,0.001
T1+T2
* 1
T3 1.163 0.747–1.811
T4 2.241 1.386–3.624
nN category ,0.001
npN1a
* 1
npN1b 1.291 0.873–1.908
npN2a 1.611 1.062–2.442
npN2b 2.521 1.617–3.932
TDs 1.399 1.037–1.887 0.028
Lymphovascular invasion 2.387 1.649–3.454 ,0.001
npN
a: novel pN category.
HR
b: hazard ratio.
CI
c: confidence interval.
*: reference category.
doi:10.1371/journal.pone.0034087.t003
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of patient prognosis. Therefore, we concluded that the npN
category had superior clinical prognostic assessment in colorectal
cancer patients.
The origin of TDs remains controversial until now. Some
authors have proposed that TDs are derived from tumor growing
inside or along lymphatic or vascular structures or nerves [8].
Others have suggested that TDs are potentially positive lymph
nodes which are no longer recognizable because of their
replacement by tumor cells [7]. Goldstein et al, in a study of 418
T3N+M0 patients with colorectal cancer, argued that the disease
free survival impact of even small TDs was significant, suggesting
that TDs of all sizes should be considered a single entity. The
number and greatest dimension of TDs should be reported
separately from lymph node metastasis [11]. In the present study,
the results showed that the npN category and nTNM classification
were superior to the pN category and TNM classification in
assessing prognosis and survival of colorectal cancer patients.
Taken together, it suggested that this new method could be used in
the TNM staging system. According to our results, TDs had an
adverse impact on prognosis and the influence of TDs on survival
is potentially similar to LNM but different from hematogenous or
implantation metastasis. We thought it was feasible that TDs was
counted as LNM in the TNM classification of colorectal cancer. In
addition, other authors have suggested that the perineural invasion
associated with TDs was likely to occur in some colorectal cancer
patients, resulting in a more adverse effect on 5-year survival
[19,24]. Thus, we should pay more attention to the TDs in clinical
practice.
There are several limitations in this study. Our study is the
result of a clinicopathological database of 513 Chinese colorectal
cancer patients. Clearly, our conclusions showed the usual
limitations of retrospective analysis from a single institution. At
present, all studies on TDs in colorectal cancer are unicentric. On
the other hand, although additional TD in the LNM confers a
worse survival, the difference is rather small compared to using
bona fide lymph node alone. Whether TD plus lymph node has
any additional significant clinical impact to patient management
need further investigation in larger samples. Therefore,we look
forward to performing larger sample studies and international
multicentric research on TDs in patients with colorectal cancer.
In conclusion, according to the results of our study, we found
that it was feasible to count TDs as metastatic lymph nodes in the
TNM staging system when assessing patients with colorectal
cancer. The new method we proposed is potentially superior to the
current 7th edition of TNM staging system for assessing prognosis
and survival of colorectal cancer patients.
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